FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
Turning Point Therapeutics Inc. (NASDAQ: TPTX) reported Q2 EPS of ($1.14), $0.07 better than the analyst estimate of ($1.21). Revenue for the quarter came in at $5.2 thousand, versus $0 reported last year.
Cash, cash equivalents and marketable securities at June 30, 2021 totaled approximately $1.1 billion. Net cash used during... More

